Cargando…
A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia
Cariprazine is a potential antipsychotic awaiting approval from the US Food and Drug Administration. It is a dopamine D(2)- and D(3)-receptor partial agonist, with higher affinity for D(3) receptors, as opposed to the D(2) antagonism of most older antipsychotic agents. Like most lipophilic antipsych...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743638/ https://www.ncbi.nlm.nih.gov/pubmed/23966785 http://dx.doi.org/10.2147/TCRM.S35137 |